Cardio Catch-Up: Boston Scientific's Farapulse PFA Shows Short Learning Curve In European Registry

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition recaps the presentation of results from EU PORIA, a European registry atrial fibrillation patients treated with Boston Scientific's Farapulse pulsed field ablation system.

Farapulse, Inc.’s Farawave PFA catheter
Boston Scientific's Farapulse PFA System • Source: Farapulse, Inc.

Results from more than 1,200 "real-world" atrial fibrillation (AF/Afib) patients treated with pulsed field ablation (PFA) in the EU PORIA registry affirmed the reliability and safety of Boston Scientific’s Farapulse PFA catheter.

Boris Schmidt from the Cardioangiologisches Centrum Bethanien in Frankfurt presented the results at the Heart Rhythm 2023 conference in...

More from Clinical Trials

More from R&D